EDGAR Filing Documents for 0001193125-04-134519

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001193125-04-134519

Filing Date

2004-08-06

Accepted

2004-08-06 17:23:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-3	dposam.htm	POS AM	464627
2	COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES	dex121.htm	EX-12.1	30636
3	CONSENT OF ERNST & YOUNG LLP	dex231.htm	EX-23.1	2182
4	CONSENT OF RECONTA ERNST & YOUNG S.P.A.	dex233.htm	EX-23.3	1944
6	GRAPHIC	g96071g88d11.jpg	GRAPHIC	14308
	Complete submission text file	0001193125-04-134519.txt		515717

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)